DOCSLIB.ORG

The Canadian Pandemic Influenza Plan for the Health Sector (2006) : 1

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
The Canadian Pandemic Influenza Plan for the Health Sector (2006) : 1 INFORMATION NOTICE The Canadian Pandemic Influenza Plan for the Health Sector (the Plan) was developed through a collaborative consultative process including representatives of Federal, Provincial, Territorial, local and regional governments, experts in the respective fields and non-government stakeholders. Development of the Plan was originally coordinated by Health Canada with direction from the Pandemic Influenza Committee, a Federal, Provincial and Territorial technical advisory committee. The 2006 edition was coordinated by the Public Health Agency of Canada. The Plan is provided for information purposes to support consistent and comprehensive planning for the health sector response to pandemic influenza across Canada by governments and other stakeholders within their respective roles and responsibilities. DISCLAIMER The views and recommendations expressed in the Plan and technical annexes were developed through a collaborative consultative process including representatives of Federal, Provincial, Territorial, local and regional governments, experts in the respective fields and non-government stakeholders. Users should seek their own independent legal and technical advice on how they will put to their own use and purpose the views, and recommendations contained in the Plan. COPYRIGHT AND PERMISSION The Plan may be used and reproduced by the User for information and educational purposes and for the User’s own pandemic influenza planning purposes. The User shall not otherwise reproduce the Plan or distribute the Plan to any third party, in whole or in part, for commercial or for any other purposes by any means, without the prior written permission of the Public Health Agency of Canada. Requests for permission may be made to the Public Health Agency of Canada. The copyright of the Plan rests with the federal Crown/federal government. Position of contact: Director, Immunization and Respiratory Infections Division Centre for Infectious Diseases Prevention and Control (CIDPC) Public Health Agency of Canada Address of contact: 100 Eglantine Driveway A.L. 0602B, Building # 6, Health Canada Ottawa ON K1A 0K9 Fax: (613) 998-6413 © Her Majesty the Queen in Right of Canada (2006) Cat. N° HP40-10/2006E-PDF ISBN 0-662-44409-4 Table of Contents Preface Sections Tab Introduction . 1 Background . 2 Preparedness . 3 Response . 4 Annexes Tab Annex A: Planning Checklists. A Annex B: Pandemic Influenza Planning Considerations in On-Reserve First Nations Communities. B Annex C: Pandemic Influenza Laboratory Guidelines. C Annex D: Preparing for the Pandemic Vaccine Response. D Annex E: Planning Recommendations for the Use of Anti-Influenza (Antiviral) Drugs in Canada During a Pandemic. E Annex F: Infection Control and Occupational Health Guidelines During Pandemic Influenza in Traditional and Non-Traditional Health Care Settings. F Annex G: Clinical Care Guidelines and Tools. G Annex H: Resource Management Guidelines for Health Care Facilities During an Influenza Pandemic. H Annex I: Guidelines for the Management of Mass Fatalities During an Influenza Pandemic . I Annex J: Guidelines for Non-Traditional Sites and Workers. J Annex K: Canadian Pandemic Influenza Plan for the Health Sector: Communications Annex . K Annex L: Federal Emergency Preparedness and Response System . L Annex M: Public Health Measures . M Annex N: Pandemic Influenza Surveillance Guidelines. N Annex O: The Role of Emergency Social Services in Planning for Pandemic Influenza in Canada. O Glossary of Terms and List of Acronyms. P The Canadian Pandemic Influenza Plan for the Health Sector I Foreword and Acknowledgements The Canadian Pandemic Influenza Plan for the Health Sector maps out how the health sector can prepare for and respond to pandemic influenza in Canada. It does so by outlining the actions that should be taken during each pandemic phase and clarifying the roles and responsibilities of those who would be involved in such a public health emergency – governments at all levels, public health officials and front-line health care workers. As a practical working tool, it also provides guidelines and checklists to assist various jurisdictions with their emergency planning. Ongoing planning for the health sector response is expected to raise the overall level of preparedness to deal with pandemic influenza in Canada and to support a sustained state of readiness based on the latest knowledge. Ultimately it is expected that advanced planning in the health and other sectors will together minimize serious illness and overall deaths, in the event of an influenza pandemic, and also ease any social or economic disruption that might be caused by a massive outbreak of the disease. Canada has had a pandemic influenza plan since 1988, and it continues to evolve based on research, evidence and lessons learned. The Canadian Pandemic Influenza Plan for the Health Sector is the product of extensive dialogue and collaboration within the Pandemic Influenza Committee (PIC). Created in 2001, PIC consists of 15 voting members, including representatives from all provinces and territories. Expertise within PIC includes Chief Medical Officers of Health, epidemiologists, virologists, communicable disease specialists, clinical, public health and laboratory specialists and an ethicist. Committee members, in turn, have been greatly assisted through a process of consultation with a wider group of stakeholders, including the health non-government organization community, local governments, emergency planners and bioethicists. As Co-Chairs of the Pandemic Influenza Committee, we have found it a continually enriching experience to watch the document evolve, and to see the sheer amount of time, dedication and commitment poured into the maintenance of the Plan. We would like to thank all of those whose contribution has helped to develop the plan and to keep it up to date. Theresa Tam Karen Grimsrud Director Deputy Provincial Health Officer Immunization and Respiratory Alberta Health and Wellness Infections Division Public Health Agency of Canada December 2006 The Canadian Pandemic Influenza Plan for the Health Sector III Pandemic Influenza Committee Federal Co-Chair North West Territories Dr. Theresa Tam, Director Mr. Jack McKinnon Immunization and Respiratory Infections Division Senior Advisor, Public Health Centre for Infectious Disease Prevention and Control Department of Health and Social Services Public Health Agency of Canada Alternate Provincial Co-Chair Ms. Cheryl Case Communicable Disease Consultant Dr. Karen Grimsrud Department of Health and Social Services Deputy Provincial Health Officer Alberta Health and Wellness Nova Scotia British Columbia Dr. Shelly Sarwal Medical Officer of Health Dr. Danuta Skowronski Nova Scotia Department of Health Physician Epidemiologist BC Centre for Disease Control Nunavut Manitoba Dr. Geraldine Osborne Associate Chief Medical Officer of Health Dr. Eilish Cleary Department of Health and Social Services Medical Officer of Health Manitoba Health Ontario Alternate Dr. Sheela Basrur Dr. Susan Roberecki Chief Medical Officer of Health Deputy Chief Medical Officer of Health Ministry of Health & Long-Term Care, Ontario Manitoba Health Alternate New Brunswick Dr. Erika Bontovics Senior Infection Control Consultant Dr. Wayne MacDonald Ministry of Health & Long-Term Care, Ontario Chief Medical Officer of Health Department of Health and Wellness, New Brunswick Prince Edward Island Alternate Dr. Lamont Sweet Ms. Lynn Cochrane Chief Health Officer Immunization and Vaccine Preventable Department of Health and Social Services Diseases Department of Health and Wellness, Quebec New Brunswick Dr. Nadia Abdelaziz Médecin conseil Newfoundland/Labrador Ministère de la Santé et des Services sociaux du Dr. Faith Stratton Québec Provincial Medical Officer of Health Alternate Department of Health and Community Services Dr. Michel Savard Alternate Médecin conseil en maladies infectieuses Ms. Cathy O’Keefe Ministère de la Santé et des Services sociaux Disease Control Nursing Specialist du Québec Department of Health and Community Services The Canadian Pandemic Influenza Plan for the Health Sector V Saskatchewan Dr. Todd Hatchette Dr. Brenda Cholin (Interim) Director of Virology and Immunology Medical Health Officer Division of Microbiology Prairie North Health Region Department of Pathology and Laboratory Medicine QE II Health Science Centre Alternate Dr. Greg Horsman Dr. Ross Findlater Medical Director Chief Medical Officer of Health Provincial Laboratory Saskatchewan Health Regina, Saskatchewan Yukon Dr. Joanne Langley, Chair of NACI Dr. Bryce Larke Division of Infectious Diseases Yukon Medical Health Officer Department of Pediatrics Yukon Health and Social Services Clinical Trials Research Center IWK Health Center Alternate Ms. Colleen Hemsley Dr. Marcus Lem, A/Director Communicable Disease Officer Primary Health Care and Public Health Yukon Health and Social Services Communicable Disease Control Division First Nations and Inuit Health Branch Bioethicist Public Health Agency of Canada Dr. Caroline Alfieri Dr. Martin Tepper Virlologist/Bioethicist Senior Medical Advisor Centre de recherche, Hôpital Ste-Justine Communicable Disease Control Program Montréal, Québec Force Health Protection Director General Health Services Public Health Agency of Canada Department of National Defence Dr. Patricia Huston Dr. Geneviève Trottier Chief, Emerging Infectious Diseases Section Veterinary Science Advisor Immunization and Respiratory Infections Division Science Advice and Biohazards Division Centre
Load more

Recommended publications
  • Summary of National Advisory Committee on Immunization (Naci) Updates of July 2, 2021
    SUMMARY OF NATIONAL ADVISORY COMMITTEE ON IMMUNIZATION (NACI) UPDATES OF JULY 2, 2021 MRNA COVID-19 VACCINES AND MYOCARDITIS On July 2, 2021, the Public Health Agency of Canada released updated advice from the National Advisory Committee on Immunization (NACI) on the use of mRNA COVID-19 vaccines. These recommendations are based on current scientific evidence and NACI's expert opinion. On June 30, 2021, Health Canada updated the product monographs, the documents that provide information for health care providers on the use of the vaccines, for the mRNA COVID-19 vaccines (Pfizer-BioNTech, Moderna) to include very rare reports of myocarditis (inflammation of the heart muscle) and pericarditis (inflammation of the tissue surrounding the heart) following vaccination. In light of these changes, NACI is providing updated advice on second doses for individuals who experienced myocarditis and/or pericarditis after receiving a first dose of an mRNA vaccine. NACI continues to strongly recommend that a complete series with an mRNA vaccine should be offered to all eligible individuals without contraindications, including those 12 years of age and older. The Pfizer-BioNTech vaccine is approved for use in people 12 years and over and the Moderna vaccine is approved for use in people 18 years of age and over. NACI is now also recommending the following: Informed consent for people receiving an mRNA vaccine should include a discussion about the very rare risk of myocarditis and/or pericarditis following immunization. As a precaution, NACI recommends that individuals who experienced myocarditis and/or pericarditis after a first dose of an mRNA vaccine should wait to get their second dose until more information is available.
    [Show full text]
  • Emergence of Highly Infectious SARS-Cov-2 Variants in Bangladesh
    Hasan et al. Trop Med Health (2021) 49:69 https://doi.org/10.1186/s41182-021-00360-w Tropical Medicine and Health LETTER TO THE EDITOR Open Access Emergence of highly infectious SARS-CoV-2 variants in Bangladesh: the need for systematic genetic surveillance as a public health strategy Mohammad Mehedi Hasan1,2, Ian Christopher N. Rocha3, Kimberly G. Ramos3, Trisha Denise D. Cedeño3, Ana Carla dos Santos Costa4, Christos Tsagkaris5, Md. Masum Billah6, Shoaib Ahmad7 and Mohammad Yasir Essar8* Abstract Bangladesh, a low-middle-income country in South Asia is facing one of its worst public health emergencies due to the COVID-19 pandemic. The increase in the number of cases from the disease, since the second half of March 2021, can potentially cause the health system overload, and has, as one of the main reasons, the non-compliance with measures of social distance and the emergence of the variants of concern in the country. This increase in the contagion curve can also provide a favorable environment for the occurrence of more mutations in the structure and genome of the virus. Therefore, there is an urge to carry out genomic surveillance programs in order to identify, moni- tor and characterize these variants, and understand whether the vaccines currently used are efective against them. Keywords: Bangladesh, SARS-CoV-2 variants, Public health, Genetic surveillance Dear editor, in the country began to increase during the middle of Te ongoing Coronavirus Disease 2019 (COVID-19) March 2021. Initially, there was a drop in the number of pandemic is a major burden to health systems world- cases during February 2021, in which the lowest monthly wide, constituting the worst health crisis in history.
    [Show full text]
  • Medical JOUR
    RHODE ISLAND M EDiCAL J ournal ZOOM – It’s a Match! Virtual National Match Day is largest on record See page 75 R SPECIAL SECTION, PART II BIOMEDICAL/TRANSLATIONAL RESEARCH in RI GUEST EDITORS: JAMES PADBURY, MD; BONGSUP CHO, PhD ApRiL 2021 VOLUME 104 • NUMBER 3 iSSN 2327-2228 REINVENTING WHAT YOU EXPECT FROM A MEDICAL PROFESSIONAL LIABILITY PROVIDER. With Coverys, you can reduce the distractions that come between diagnosis and outcomes. By leveraging claims data and analytics plus innovative educational resources, we’re helping doctors and administrators reduce distractions and focus on improving clinical, operational, and financial outcomes.Visit coverys.com Insurance products issued by ProSelect® Insurance Company (NE, NAIC 10638) and Preferred Professional Insurance Company® (NE, NAIC 36234). RHODE ISLAND M EDICAL J OURNAL 15 Translational Research: The Time is Now JAMES F. PADBURY, MD BONGSUP P. CHO, PhD GUEST EDITORS James F. Padbury, MD Bongsup Cho, PhD 17 The Time is NOW: Filling the Gaps in Treatment of Opioid-Exposed Infants: A Prospective, Pragmatic, Randomized Control Drug Trial ADAM J. CZYNSKI, DO; ABBOT R. LAPTOOK, MD 22 COBRE on Opioid and Overdose: A Collaborative Research-Based Center Addressing the Crises in Rhode Island and Beyond TRACI C. GREEN, PhD, MSc; ELIANA KAPLOWITZ, BA; KIRSTEN LANGDON, PhD; JACLYN M.W. HUGHTO, PhD, MPH; WILLIAM C. GOEDEL, PhD; ADAM J. CZYNSKI, DO; GAYLE FRASER, BS; JOSIAH RICH, MD, MPH 27 Brown University COBRE Center for Addiction and Disease Risk Exacerbation PETER M. MONTI, PhD; JENNIFER W. TIDEY, PhD; JASJIT S. AHLUWALIA, MD 32 The Center of Biomedical Research Excellence (COBRE) for Perinatal Biology – Accomplishments, Impact, and Long-term Results SUNIL K.
    [Show full text]
  • Coronavirus Fact Sheet
    CORONAVIRUS FACT SHEET The Assembly of First Nations (AFN) is providing this overview of the coronavirus, and information on resources in your region. As the situation is evolving rapidly, please visit the Public Health Agency of Canada and Indigenous Services Canada for the most updated information. Canada’s Chief Public Health Officer, Dr Theresa Tam, has assessed the public health risk of COVID-19 within Canada to be low. • Coronaviruses in general are part of a large family of viruses which may cause illness in people and in animals. Human coronaviruses are common and are typically associated with mild illnesses, like the common cold. • Coronavirus Disease 2019 (COVID-19) is a new disease that has not been previously identified in humans. • Currently there is NO vaccine to protect against 2019 novel coronavirus infection. • Those who are infected with COVID-19 may have little to no symptoms. You may not know you • The flu vaccine doesnot protect against have symptoms of COVID-19 because they are coronaviruses. similar to a cold or flu. • For now, there is no specific treatment. Most o Symptoms may take up to 14 days to appear people with the common coronavirus illness after exposure to COVID-19. This is the lon- will recover on their own and your health care gest known infectious period for this disease. provider may recommend steps you can take to relieve symptoms. o Symptoms have included fever, cough, difficulty breathing, pneumonia in both lungs. • Common prevention measures for viruses, such as the COVID-19 and influenza, include: • Coronavirus infections are diagnosed by a health care provider based on symptoms and confirmed o Regular hand washing with soap and warm through laboratory tests.
    [Show full text]
  • Behind the Mask
    BEHIND THE MASK: Determinants of Nurses’ Adherence to Recommended Use of Facial Protective Equipment to Prevent Occupational Transmission of Communicable Respiratory Illness in Acute Care Hospitals by Kathryn Anne Nichol A thesis submitted in conformity with the requirements for the degree of Doctor of Philosophy Institute of Medical Science University of Toronto © Copyright by Kathryn Anne Nichol (2010) BEHIND THE MASK: Determinants of Nurses’ Adherence to Recommended Use of Facial Protective Equipment to Prevent Occupational Transmission of Communicable Respiratory Illness in Acute Care Hospitals Kathryn Anne Nichol Doctor of Philosophy Institute of Medical Science University of Toronto 2010 Abstract (max 350w) Background - Communicable respiratory illness is a serious occupational threat to healthcare workers. A key reason for occupational transmission is failure to implement appropriate barrier precautions. Facial protective equipment, including surgical masks, respirators and eye/face protection, is the least adhered to type of personal protective equipment used by healthcare workers, yet it is an important barrier precaution against communicable respiratory illness. Objectives - To describe nurses‘ adherence to recommended use of facial protective equipment and to identify the factors that influence adherence. Methods - A two-phased study was conducted. Phase 1 was a cross-sectional survey of nurses in selected units of six acute care hospitals in Toronto, Canada. Phase 2 was a direct observational study of critical care nurses. ii Results – Of the 1074 nurses who completed surveys (82% response rate), 44% reported adherence to recommended use of facial protective equipment. Multivariable analysis revealed four organizational predictors of adherence: ready availability of equipment, regular training and fit testing, organizational support for health and safety, and good communication.
    [Show full text]
  • Covid-19: How Doctors and Healthcare Systems Are Tackling Coronavirus
    BMJ 2020;368:m1090 doi: 10.1136/bmj.m1090 (Published 18 March 2020) Page 1 of 5 Feature BMJ: first published as 10.1136/bmj.m1090 on 18 March 2020. Downloaded from FEATURE GLOBAL HEALTH Covid-19: how doctors and healthcare systems are tackling coronavirus worldwide As coronavirus continues to spread, doctors and healthcare systems are facing a multitude of challenges at all stages of the pandemic Janice Hopkins Tanne 1, Erika Hayasaki 2, Mark Zastrow 3, Priyanka Pulla 4, Paul Smith 5, Acer Garcia Rada 6 1New York; 2Boston; 3Seoul; 4Bangalore; 5Sydney; 6Madrid United States least one site already open in the New York City suburb of New Rochelle, handling around 250 people a day. The United States declared a national emergency on 13 March The American Medical Association, which represents about as covid-19 spread to 49 of the country’s 50 states. half of US doctors, called the emergency declaration “necessary http://www.bmj.com/ President Donald Trump announced $50bn (£42.1bn; €45.6bn) to help ensure that America’s health system has sufficient to help combat the virus, as well as powers to waive laws and resources.” Meanwhile, some doctors complained that they did restrictions to make care more available, such as through not have test kits and were short of protective equipment. Other telehealth and allowing doctors to practise in states they are not physicians said that access to Medicaid, insurance for poor licensed in. patients, should be improved and sped up. The president—who has tested negative for covid-19 after At a 15 March press conference Anthony Fauci, head of the contact with an infected Brazilian official—said that many more National Institute of Allergy and Infectious Diseases, told the on 30 April 2020 by guest.
    [Show full text]
  • COVID-19: Recovery and Re-Opening Tracker By: Trevor Lawson, Lara
    COVID-19: Recovery and Re-opening Tracker By: Trevor Lawson, Lara Nathans, Meghan Hillstrom, Marco Fimiani, Nicole Naglie As Governments and businesses turn their minds toward the recovery and re-opening of the economy, our team is closely monitoring updates from governments across Canada. The following summarizes the recovery and re-opening measures which have been announced to date in each jurisdiction. We will continue to update this summary as further measures are introduced across the country. This roundup was last updated on May 8,10, 2020. To see what has changed since our last update, please download our blackline, here. Federal May 8, 2020: The Canadian Department of Justice established an Action Committee on Court Operation in Response to COVID-19 which will focus on developing court-specific health and safety guidelines (link). May 4, 2020: The Government of Canada created the COVID-19 Supply Council to advise the government on the procurement of critical goods and services required as part of Canada’s COVID-19 response and recovery (link). April 24, 2020: The Government of Canada released a backgrounder on the fundamentals of return to work plans (link). British Columbia May 7, 2020: The Government of British Columbia announced that Phase 2 of the Restart Plan is scheduled to begin after the May long weekend (link). May 7, 2020: The Government of British Columbia launched a renewal plan for surgeries that were postponed due to the COVID-19 pandemic (link). May 6, 2020: The Government of British Columbia announced the province’s Restart Plan, which will begin mid-May (link).
    [Show full text]
  • Covid-19 in Canadian Media a Weekly Media Summary for Professional Communicators
    COVID-19 IN CANADIAN MEDIA A WEEKLY MEDIA SUMMARY FOR PROFESSIONAL COMMUNICATORS For the week of MAY 10 – MAY 16, 2020 1 A NOTE TO THE READER This report reflects the findings of Canadian media coverage associated with the COVID-19 pandemic. The Coronavirus case and media trends which are the foundation of this analysis portend earned media opportunities in the days following the flattening of infection and mortality rates. Just as these rates change from one country to the next, so do the pace and extent of earned media opportunities. We do not assert our expertise in predicting the infections curves, but rather, suggest only conditionally that if the infection and media patterns in Canada reflect trends in other countries, we can expect certain pathways to emerge across all countries. As such, please consider these findings “directional” rather than “statistically significant”. Please keep in mind that both Coronavirus and media trends are shown at the national and provincial level, rather than local level. While certain locales may see infections and coverage continue to surge, other parts of the country may experience a flatter curve more quickly. As such, deceleration in one area within a country may offset local surges in another. Unless otherwise indicated, the data reflects Canadian coverage in aggregate. This report is a summary of Canadian earned news This analysis features earned media coverage media content only, published between May 10 and from over 50,000 unique media outlets across May 16, focused on discussions related to COVID-19 both traditional and digital media sources, and Coronavirus.
    [Show full text]
  • Middlesex-London Board of Health
    AGENDA MIDDLESEX-LONDON BOARD OF HEALTH Thursday, February 27, 2020, 7:00 p.m. 399 Ridout Street North, London, Ontario Side Entrance, (recessed door) MLHU Boardroom MISSION - MIDDLESEX-LONDON HEALTH UNIT The mission of the Middlesex-London Health Unit is to promote and protect the health of our community. MEMBERS OF THE BOARD OF HEALTH Ms. Maureen Cassidy (Chair) Ms. Aina DeViet (Vice-Chair) Mr. John Brennan Mr. Michael Clarke Ms. Kelly Elliott Ms. Tino Kasi Ms. Arielle Kayabaga Mr. Ian Peer Mr. Bob Parker Mr. Matt Reid SECRETARY-TREASURER Dr. Christopher Mackie DISCLOSURE OF CONFLICTS OF INTEREST APPROVAL OF AGENDA MINUTES Approve: January 23, 2020 – Board of Health meeting Receive: February 6, 2020 – Finance & Facilities Committee Meeting February 13, 2020 - Finance & Facilities Committee Meeting 1 Item Item # Delegation Recommendation Information Link to Report Name and Number Overview and Lead Additional Information Reports and Agenda Items 2020 Annual Service Plan (Final) Finance & Facilities Committee To provide an update on the February 6 Meeting Update: February 6 and February 6, 2020 and 13, 2020 Finance & Facilities 13, 2020 Agenda Committee meetings. 1 x x x Minutes (Report No. 005-20A & 005-20B) Lead: Kelly Elliott, Chair, Finance & February 13, 2020 Facilities Committee Agenda Minutes To provide an update on the February Governance Committee Meeting 27, 2020 Governance Committee Update: February 27, 2020 February 27, 2020 2 x x x meeting. Agenda (Verbal) Lead: Chair, Governance Committee To request approval to forward the Middlesex-London Health Unit’s Public Public Health Modernization – Health Modernization submission to the Board of Health Submission 3 x x Appendix A Ministry of Health.
    [Show full text]
  • Conference Transcripts
    SARS in the Context of A New York Academy of Sciences Conference, Emerging Infectious Threats May 17, 2003 CONFERENCE TRANSCRIPT Welcome Ellis Rubinstein, Chief Executive Officer, New York Academy of Sciences An Academy Tradition of Convening Scientists Welcome to the New York Academy of Sciences. I think we have a packed room, so I think we should start. I am Ellis Rubinstein, the chief executive officer of the Academy, and it is a pleasure to welcome you all here. As some of you may know, I've been CEO here for only six months. That's in contrast to the fact that this place has been here for 186 years and, some people might not know, is the third oldest, I think, sci- entific society that's been continuously running, and it's had an extremely wonderful history in many ways. Thomas Jefferson was a member, and Darwin was a member, so it's been global for a long time. I guess in my mind some of the best things it has done is to convene people across disciplines and barriers on important topics. Some people here may or may not know that the Academy was the first organiza- tion to run a major meeting on AIDS. The meeting that we're going to hold here today is in keeping with a tradition that has gone back for some time of doing these kinds of important convening tasks. I would say, I think quite safely, that never in the history of the Academy could they have produced a meeting as rapidly as this one was done.
    [Show full text]
  • Canadian Tuberculosis Standards 7 Th Edition Appendix E: Contributors
    Canadian Tuberculosis Standards 7 th Edition Appendix E: Contributors To promote and protect the health of Canadians through leadership, partnership, innovation and action in public health. — Public Health Agency of Canada Canadian Tuberculosis Standard, 7th edition Également disponible en français sous le titre : Normes canadiennes pour la lutte antituberculeuse, 7ième édition To obtain copy of the report, send your request to: Centre for Communicable Diseases and Infection Control Public Health Agency of Canada E-mail: [email protected] This publication can be made available in alternative formats upon request © Her Majesty the Queen in Right of Canada, 2014 This publication may be reproduced for personal or internal use only without permission provided the source is fully acknowledged. However, multiple copy reproduction of this publication in whole or in part for purposes of resale or redistribution requires the prior written permission from the Minister of Public Works and Government Services Canada, Ottawa, Ontario K1A 0S5 or [email protected] PDF Cat.: HP40-18/2014E-PDF ISBN: 978-1-100-23171-6 Pub.: 140216 1 | CANADIAN TUBERCULOSIS STANDARDS – 7TH EDITION TABLE OF CONTENTS Contributors ............................................................................................................................................ 2 Editor….. .................................................................................................................................................. 2 Associate Editors ...................................................................................................................................
    [Show full text]
  • Maladies Infectieuses Émergentes » Actualités Et Propositions
    Actes du 5e séminaire « Maladies Infectieuses Émergentes » Actualités et propositions 22 mars 2016 Propositions prioritaires 1. Encourager la recherche sur la prévision, le dépistage et la détection précoces des nouveaux risques infectieux 2. Développer la recherche et la surveillance sur la transmission des agents infectieux entre l’animal et l’humain, en les renforçant, en particulier dans les zones inter- tropicales, « points chauds » (« hotspots ») pour le risque infectieux, grâce à des aides publiques 3. Poursuivre, dans ces zones, le développement et le soutien des actions de prévention et de formation des acteurs de santé locaux et favoriser la culture du risque dans les populations 4. Prendre en charge les patients de façon adaptée afin de favoriser l'adhésion aux soins et aux mesures visant à réduire la diffusion d'une épidémie 5. Développer la sensibilisation et l’entraînement des acteurs politiques et sanitaires, afin de mieux les préparer à la réponse aux crises de typologie nouvelle 6. Réviser les logiques de gouvernance en s’appuyant sur tous les modes de communication disponibles, intégrant les nouveaux outils d’information collaborative 7. Développer les recherches économiques sur la lutte contre les MIE, tenant compte des déterminants spécifiques afin d’équilibrer les démarches préventives et curatives 1- Introduction première a été donnée par le Dr Peter Daszak (Président d’EcoHealth Alliance et La 5ème édition du séminaire de l'Ecole du responsable du programme USAID-EPT- Val-de-Grâce avait pour objectifs PREDICT), et l'autre par le Dr. Patrick l’approche globale de l’émergence de Lagadec (ancien directeur de recherche à nouveaux agents infectieux, la mise en l'Ecole Polytechnique).
    [Show full text]